Researchers report a recent clinical trial where adding a second hormone mimic to tirzepatide appeared to make it work better, though they flag limits.
Recap by typeshit. Post by Facebook on Facebook.
Pratt, a psychology professor who studies the circuits behind food motivation, walks through what neuroscience shows about these drugs.
Lilly's pill had major heart events in 4.2% of patients vs 5.0% on insulin glargine. The Clinical Trial Vanguard argues rivals now need to show benefit, not just safety.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
The aging doctor shares a headline saying new studies point to GLP-1 drugs slowing the biological clock, and notes himself that more research is needed.
An investigation follows counterfeit weight loss injections from a single warehouse back to the international network that supplies them.
Food brands are marketing products to people on GLP-1 drugs, and nutritionists say the label alone tells you little about what's actually in them.
Loading…